OTC · WEQL
WellQuest Medical & Wellness Corporation
$0.00$0.00 (0.0%)
WellQuest Medical & Wellness Corporation’s quoted price sits in the lower half of its reported 52-week range, 93.55% below the high.
Loading market information…
OTC · NWCI · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow NewCardio, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
NewCardio, Inc. is a company dedicated to cardiac diagnostics and related services. Its primary objective is the research, creation, and market introduction of exclusive software platform technologies. These innovations are designed for two main applications: the non-invasive diagnosis and continuous monitoring of cardiovascular diseases (CVD), and the assessment of cardiac safety for experimental drugs. The company's underlying technology analyzes the heart's electrical activity in real-time and in three dimensions, using data gathered from the body's surface via standard 12-lead electrocardiogram (ECG) electrodes. NewCardio is also actively developing several products. QTinno, for instance, is an automated solution for cardiac safety, utilizing algorithms to automatically measure, analyze, and report on collected ECGs, thereby streamlining traditional manual or semi-automated methods. Another product, CardioBip, is a mobile ECG system for remote transmission, comprising a portable recording and transmitting device along with web-based software that receives, processes, and interprets the data. Furthermore, the company is progressing with my3KG, a software application intended to provide a comprehensive method for evaluating cardiac electrical activity across both time and space. NewCardio, Inc. was founded in 2004 and is headquartered in Branchburg, New Jersey.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:33 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
WellQuest Medical & Wellness Corporation’s quoted price sits in the lower half of its reported 52-week range, 93.55% below the high.
$0.00$0.00 (0.0%)
FluoroPharma Medical, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Caliber Imaging & Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.5% below the high.
$0.00$0.00 (0.0%)
Nemaura Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.00$0.00 (0.0%)
New York Health Care, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Rebus Holdings, Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
Sienna Biopharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Lombard Medical, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
